The C-type lectin receptor-Syk (spleen tyrosine kinase) adaptor CARD9 facilitates protective antifungal immunity within the central nervous system (CNS), as human deficiency in CARD9 causes susceptibility to fungus-specific, CNS-targeted infection. CARD9 promotes the recruitment of neutrophils to the fungus-infected CNS, which mediates fungal clearance. In the present study we investigated host and pathogen factors that promote protective neutrophil recruitment during invasion of the CNS by Candida albicans. The cytokine IL-1β served an essential function in CNS antifungal immunity by driving production of the chemokine CXCL1, which recruited neutrophils expressing the chemokine receptor CXCR2. Neutrophil-recruiting production of IL-1β and CXCL1 was induced in microglia by the fungus-secreted toxin Candidalysin, in a manner dependent on the kinase p38 and the transcription factor c-Fos. Notably, microglia relied on CARD9 for production of IL-1β, via both transcriptional regulation of Il1b and inflammasome activation, and of CXCL1 in the fungus-infected CNS. Microglia-specific Card9 deletion impaired the production of IL-1β and CXCL1 and neutrophil recruitment, and increased fungal proliferation in the CNS. Thus, an intricate network of host-pathogen interactions promotes antifungal immunity in the CNS; this is impaired in human deficiency in CARD9, which leads to fungal disease of the CNS.
T he central nervous system (CNS) is invaded by microorganisms during systemic infections, yet the mechanisms of CNSspecific, antimicrobial immunity remain poorly understood. This is particularly true for CNS fungal infections, which present unmet diagnostic and treatment challenges, leading to unacceptably high mortality rates (>50%) 1 . Fungal CNS invasion is enhanced by fungus-specific risk factors, including HIV infection, neutropenia, corticosteroid use and Bruton's tyrosine kinase inhibition 1 . However, the most striking human risk factor for selective CNS fungal infection susceptibility is inherited deficiency of the C-type lectin receptor (CLR)-spleen tyrosine kinase (Syk) adaptor CARD9.
CARD9 relays fungus-sensing signals downstream of the CLR superfamily of pattern recognition receptors, including Dectin-1, Dectin-2, Dectin-3 and Mincle. The kinase Syk is recruited to phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) sequences of CLRs, or their signaling partner FcRγ, to form the CARD9-BCL10-MALT1 (BCL is 'B-cell lymphoma/leukemia' and MALT is 'mucosa-associated lymphoid tissue') signalosome, which activates downstream effectors, including nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), NLRP3 inflammasome and mitogen-activated protein kinase (MAPK) signaling 2 . CARD9-deficient patients manifest fungus-specific infection susceptibility, predominantly in the CNS by Candida albicans [2] [3] [4] . We have previously shown that CARD9 deficiency in humans and mice confers a fungus-and brain-specific defect in neutrophil recruitment, which is detrimental to control of CNS fungal invasion 5 . However, the CNS cellular and molecular cues that promote protective neutrophil recruitment during C. albicans invasion, and their dependence on CARD9 in vivo, remain unknown.
In the present study, we systematically investigated host and pathogen factors that promote protective neutrophil influx into the C. albicans-infected CNS for a better understanding of the pathogenesis of human CARD9 deficiency. We uncovered an intricate pathway by which the C. albicans-secreted toxin Candidalysin engages microglia to produce the interleukin IL-1β and the chemokine ligand CXCL1 for protective recruitment of C-X-C chemokine Articles NATuRe IMMuNoLogy receptor 2 (CXCR2)-expressing neutrophils. Importantly, microglial IL-1β and CXCL1 production depends on CARD9, and specific deletion of microglial CARD9 impairs neutrophil recruitment to the C. albicans-infected CNS. Collectively, our data unveils complex host-pathogen interactions that recruit protective neutrophils during fungal CNS invasion and reveals the mechanism that underlies CNS fungal susceptibility in CARD9 deficiency.
Results

CLR functional redundancy during fungal CNS invasion.
As has been previously shown, CARD9 is essential for protective CNS immunity against C. albicans, principally through promoting early neutrophil recruitment (Fig. 1a) . We first investigated the relative contribution of CARD9-coupled CLRs, which are expressed by brain-resident microglia (see Supplementary Fig. 1 ), in mediating this protective neutrophil recruitment. We infected mice deficient ), and measured brain neutrophil accumulation at 24 h post-infection (see Supplementary Fig. 2 ). We chose this time point because it is the peak of the neutrophil response in wild-type (WT) animals, and neutrophil depletion at this time point increases susceptibility to fungal invasion of the brain 5 . Animals individually deficient in CARD9-coupled CLRs recruited neutrophils to the infected brain normally (Fig. 1b) . Despite this, we observed increases in fungal burdens of the brain at 72 h post-infection in mice deficient in Dectin-1 or Dectin-2, but not Dectin-3 or Mincle (Fig. 1c) , suggesting that Dectin-1 and Dectin-2 employ neutrophil recruitment-independent mechanisms to protect against fungal proliferation in the brain. Indeed, braininfiltrating neutrophils from Dectin-1-and Dectin-2-deficient animals exhibited reduced fungal phagocytosis (see Supplementary  Fig. 3 ), consistent with previous findings 6 . 
-/-mice and their littermate controls were infected as above and analyzed for fungal burden in the brain (right: WT, n = 7 and Malt1 -/-, n = 5) and neutrophil recruitment to the brain at 24 h post-infection (left: WT, n = 5 and Malt1 -/-, n = 5). In all cases, WT refers to appropriate matched control animals for each knockout line for gender, age and genetic background. Individual points represent different mice. Data are pooled from two independent experiments and are shown as mean ± s.e.m., and analyzed using the unpaired, two-tailed, Student's t-test (a (left), b) or the two-tailed, Mann-Whitney U-test (a (right), c, d). *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001.
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To activate CARD9-dependent signaling, phosphorylation occurs on the ITAM sequence within the intracellular tail of Dectin-1 or FcRγ, with which Dectin-2, Dectin-3 and Mincle associate. Therefore, we assessed whether deletion of all four CLRs affected the neutrophil response in the infected brain. We used mice doubly deficient in Dectin-1 and FcRγ (Clec7a -/-
Fcerg1
-/-), and found that loss of both Dectin-1 and the FcRγ-coupled CLRs phenocopied Card9 deficiency with greatly decreased neutrophil recruitment and correspondingly increased fungal burdens in the brain (Fig. 1b,c) . Taken together, CARD9-coupled CLRs functionally compensate to mediate neutrophil recruitment-dependent protection against C. albicans CNS invasion.
MALT1 is required for defense against CNS candidiasis. The CARD9-MALT1-BCL10 signalosome is necessary for transducing fungus-sensing intracellular signals. Human deficiencies of MALT1 or BCL10 cause defective innate and adaptive immune responses, and many of these patients die in childhood from bacterial and viral infections 2 . Human MALT1 deficiency in addition manifests with mucosal candidiasis, suggesting that antifungal immunity is impaired in these patients. However, whether MALT1 deficiency also predisposes to brain-targeted candidiasis is unknown. To test this, we infected MALT1-deficient mice and assessed control of C. albicans growth in the CNS.
Malt1
-/-animals recruited neutrophils to the brain similar to the WT; however, these animals exhibited uncontrolled brain fungal growth at 72 h post-infection (Fig. 1d) . Therefore, MALT1 is critical for protective CNS immunity against C. albicans, although the MALT1-dependent protective mechanisms operating in this tissue are independent of neutrophil recruitment, unlike CARD9.
Candida drives CNS neutrophil influx via IL-1β and CXCL1.
To determine the local cues that recruit protective neutrophils in the infected CNS, we examined key cytokine and chemokine circuits using gene-deficient mice. We first infected IL-1 receptor (IL-1R)-deficient mice, because production of IL-1β by human peripheral blood mononuclear cells, after fungal stimulation, is CARD9 dependent 5, 7 , and because IL-1R was previously shown to recruit neutrophils to fungus-infected mucosal tissues 8, 9 and the bacteriainfected brain 10 . After C. albicans challenge, IL-1R-deficient mice phenocopied Card9-deficient mice, with a loss of early brain neutrophil recruitment and accompanying increased fungal burdens in the brain (Fig. 2a,b) . Consistent with this, loss of the IL-1R signaling adaptor MyD88 caused similar defects in neutrophil recruitment and control of fungal proliferation in the infected brain (Fig. 2a,b) .
We next assessed which IL-1R ligands were important for driving CNS protection by infecting mice deficient in IL-1α, IL-1β or both. Mice lacking IL-1α had a small reduction in neutrophil numbers and a slight increase in fungal burden of the brain at 24 h postinfection (Fig. 2a,b) . However, the lack of IL-1α was compensated for by IL-1β, because Il1a -/-animals recovered and controlled fungal infection of the brain similar to WT by 72 h post-infection (Fig. 2b) . In keeping with the critical contribution of IL-1β, mice deficient in IL-1β, or both IL-1α and IL-1β, exhibited significantly reduced neutrophil accumulation and were highly susceptible to fungal invasion of the brain (Fig. 2a,b) . Therefore, IL-1β is a critical mediator of neutrophil recruitment to promote control of C. albicans infection in the brain.
Downstream of IL-1R, local chemotactic mediators recruit immune cells to infected tissues. Previously, we have shown that the CNS neutropenia, observed in mouse and human CARD9 deficiency, is not caused by neutrophil-intrinsic chemotaxis defects 5 , but by insufficient local production of soluble chemotactic mediators. However, which of the several chemoattractants and their receptors recruit(s) protective neutrophils to the C. albicans-infected CNS is unknown.
CARD9 was shown to drive production of the CXCR2 ligands CXCL1 and CXCL2 during inflammatory arthritis 11 and murine subcutaneous phaeohyphomycosis 12 . During systemic C. albicans infection, the chemokine receptor CCR1 drives renal neutrophil accumulation and immune-related kidney destruction 13 , the leukotriene B 4 (LTB 4 ) receptor LTB4R1 promotes detrimental pulmonary neutrophil accumulation 14 and CXCR1 mediates neutrophil-dependent fungal killing in the kidney 15 . However, the role of these receptors in CNS anti-Candida immunity is unknown, and CXCR2 and the fMet-Leu-Phe (fMLP) receptor FPR1 have not been examined in relation to anti-Candida defense.
To test the relative dependence on these major neutrophiltargeted chemoattractant receptors to protect the fungus-infected brain, we infected mice deficient in CCR1, CXCR1, CXCR2, LTB4R1 or FPR1, and measured neutrophil recruitment and fungal burdens in the brain. We found no involvement of the CCL3-CCR1, CXCL5-CXCR1, LTB 4 -LTB4R1 or fMLP-FPR1 axes in controlling fungal brain infection, in line with normal early neutrophil recruitment in infected Ccr1
-/-and Fpr1 -/-animals ( Fig. 2c,d and see Supplementary Fig. 4 ). In contrast, CXCR2-deficient mice had greatly reduced neutrophil accumulation and correspondingly greatly increased fungal growth in the brain (Fig.  2c,d ). This data demonstrates the importance of the CXCR2 axis in neutrophil-mediated protection against C. albicans brain infection.
Next, we wondered which CXCR2 ligand could recruit protective neutrophils to the fungus-infected brain. We infected Cxcl1 -/-mice that lack expression of the potent neutrophil chemokine CXCL1. Notably, these animals had decreased neutrophil recruitment to the brain post-infection, and exhibited a similar CNS invasion susceptibility phenotype to Cxcr2 -/-mice ( Fig. 2c,d) . Therefore, the CXCL1-CXCR2 chemokine axis is critical for protection against C. albicans brain invasion by recruiting protective neutrophils. Importantly, this data indicates that the reduced CXCL1 in the human, CARD9-deficient, C. albicans-infected cerebrospinal fluid is biologically relevant and important 5 .
IL-1β activates CXCL1 in the fungus-infected brain. As both IL-1β and CXCL1 were required for protection, we investigated whether their activation in the infected brain was simultaneous or sequential. We measured IL-1β and CXCL1 in brain homogenates at 24 h post-infection in animals lacking these inflammatory mediators. We found no defect in IL-1β levels in CXCL1-deficient, infected brains; however, we discovered a significant defect in CXCL1 production in the absence of IL-1β (Fig. 3a) . To define the IL-1β-dependent cellular sources of CXCL1 in the brain, we infected WT and IL-1β-deficient mice and used intracellular flow cytometry. CXCL1 and pro-IL-1β were produced by multiple myeloid phagocytes in the fungus-infected brain, including resident microglia, the most numerous immune cells in the brain, and recruited Ly6C hi monocytes that have been implicated in controlling C. albicans CNS invasion 16 , and the neutrophils themselves (Fig. 3b) . It is interesting that Il1b -/-microglia recovered from C. albicans-infected brains had a profound defect in CXCL1 production, exhibiting significant reductions under every ex vivo restimulation condition tested (Fig. 3c) . Ly6C hi monocytes isolated from Il1b -/-C. albicans-infected brains produced less CXCL1 when restimulated ex vivo with lipopolysaccharide (LPS), with no differences detected under non-stimulated or zymosan-stimulated conditions. Neutrophil production of CXCL1 did not differ between the two mouse groups (Fig. 3c) . Therefore, IL-1β is required for subsequent CXCL1 production from resident microglia and recruited monocytes, which in turn recruits CXCR2-expressing neutrophils to the fungus-infected brain.
Candidalysin is a fungal avirulence factor in the brain. Use of genetically deficient mice allowed us to map the host pathway promoting protection against C. albicans brain infection, in which
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NATuRe IMMuNoLogy IL-1β-IL-1R-MyD88 signaling activates CXCL1 production by resident microglia and recruited monocytes to mobilize neutrophils into the CNS. To identify the pathogen-associated factors that induce this protective host pathway, we infected animals with C. albicans strains lacking known virulence factors and assessed neutrophil recruitment and IL-1β and CXCL1 production in the infected brain.
C. albicans hyphae are the predominant CNS-invasive morphological forms of C. albicans 5 and hyphal formation is associated with important virulence traits such as toxin and protease production, adhesion, invasion and immune system activation 17 . Thus, we first asked whether neutrophil recruitment was impaired during infection with the hgc1Δ/Δ C. albicans strain which cannot form filaments in vivo 18 . Indeed, infection with hypha-deficient hgc1Δ/Δ C. albicans significantly impaired neutrophil recruitment and enhanced fungal invasion of the CNS tissue relative to the isogenic WT C. albicans strain (Fig. 4a) . Thus, it is striking that filamentation is not required for C. albicans invasion of brain tissue, in contrast to other organs such as the kidney 18 . Candidalysin is a recently described peptide toxin encoded by ECE1 and expressed exclusively by C. albicans hyphae 19 . Candidalysin has been shown to mediate epithelial cell damage via pore formation in the plasma cell membrane, resulting in IL-1α release and proinflammatory cytokine production. Hence, Candidalysin-null mutants were highly attenuated in murine oropharyngeal and vulvovaginal candidiasis models [19] [20] [21] . Instead, we found that lack of Candidalysin promoted brain infection, and that this phenotype was specific to the candidalysin peptide because mutant strains deficient in the entire gene (ece1Δ/Δ), or specifically in the Candidalysinencoding portion of the gene (ece1Δ/Δ + ECE1 Δ184-279 ), were both hypervirulent for C. albicans brain invasion (Fig. 4b) .
The increased ability of the Candidalysin-null mutants to proliferate within the brain correlated directly with the degree of neutrophil recruitment. We found an almost complete absence of neutrophils in the brains of WT animals infected with Candidalysin-null strains, and observed hyphal forms growing in the brain parenchyma without neutrophilic reaction (Fig. 4c) . In contrast, the Candidalysin-producing parental strain and the reintegrant control strain promoted neutrophil recruitment at 24 h post-infection, and these neutrophils clustered around invading hyphae (Fig. 4c ). In line with the absence of neutrophils in the brains of mice infected with Candidalysin-null strains, IL-1β , n = 5-7. Data are pooled from two to three independent experiments and are shown as mean ± s.e.m., analyzed using the unpaired, two-tailed, Student's t-test (a,c) or the two-tailed, Mann-Whitney U-test (b,d). *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001.
NATuRe IMMuNoLogy and CXCL1 were significantly reduced in brain homogenates from animals infected with these strains (Fig. 4d) . Therefore, Candidalysin is a key fungal factor that activates the IL-1β-CXCL1 protective pathway in vivo. Notably, in contrast to its role in the mucosa, Candidalysin acts as an avirulence factor in the brain by instigating protective host CNS immunity, underscoring the tissue-specific opposing roles that a microbial factor may play during infection with the same pathogen 17 . -/-(n = 5) and Il1b -/-(n = 6) animals were infected as in Fig. 1 ; the brains were isolated at 24 h post-infection and analyzed for CXCL1 or IL-1β production by ELISA. Data are pooled from two independent experiments and were analyzed using the unpaired, two-tailed, Student's t-test. b, The relative proportions of myeloid cell populations (gated within live CD45 + singlets) in the uninfected (n = 6) and 24 h infected WT (n = 6) brain (left), and the relative proportion of myeloid cell populations producing CXCL1 (n = 3) or pro-IL-1β (n = 9) in the 24 h infected brain (right). For the latter, total CD45 + CXCL1(or IL-1β) + cells were first gated and then the cell types were defined within this initial gate with lineage markers (see below), using samples from the unstimulated condition. Data are shown as the mean ± s.e.m. c, WT (n = 3) and Il1b -/-mice (n = 4) were infected with 2 × 10 5 c.f.u. of C. albicans and the brain cells analyzed for CXCL1 production by intracellular flow cytometry 24 h later. Brain cells were restimulated ex vivo with 62.5 µg ml -1 depleted zymosan or 1 µg ml -1 LPS for 4 h in the presence of 5 µg ml -1 brefeldin A. Representative plots from the LPS-stimulated condition are gated on microglia (top: CD45 , showing corresponding Cxcl1 -/-cells to gating controls. In all panels, 'wild type' refers to appropriate matched control animals for each knockout line for gender, age and genetic background. Each symbol represents an individual mouse. Data are shown as mean ± s.e.m., and were analyzed using the unpaired, two-tailed, Student's t-test. *P < 0.05, **P < 0.01.
Articles NATuRe IMMuNoLogy
We wondered next whether other secreted proteins associated with C. albicans hyphae also activate protective neutrophil responses in the brain. Secreted aspartyl proteases (Saps) are enzymes with extracellular proteolytic activity linked to virulence 22 . C. albicans Saps promote neutrophil recruitment during vulvovaginal candidiasis in mice 23, 24 . Expression of the SAP4-6 subfamily is coordinately regulated with hyphal formation 22 , so we tested whether these hyphae-associated Saps contributed toward virulence during brain invasion. WT animals infected with the triple-deficient strain sap4/5/6Δ/Δ had comparable fungal burdens in the brain to animals infected with the complemented control strain (Fig. 4e) . In line with this, we saw no difference in CNS neutrophil recruitment in these animals, indicating that C. albicans Saps exhibit tissuespecific roles in promoting neutrophil recruitment during infection 23, 24 (Fig. 4e) . Therefore, protective CNS neutrophil recruitment is activated by candidalysin, and not by other enzymes secreted by C. albicans hyphae.
Candidalysin drives microglial IL-1β and CXCL1 in vivo. Next we sought to define the Candidalysin-responsive, CNS-immune cells post-infection. We infected WT mice with the parental strain of C. albicans (BWP17) or the Candidalysin-null strain (ece1Δ/Δ), and analyzed IL-1β and CXCL1 production at 24 h post-infection. Although all brain phagocytes produced both IL-1β and CXCL1, microglia were the only population to exhibit dependence on Candidalysin, because microglia isolated from ece1Δ/Δ-infected brains produced significantly less IL-1β and CXCL1 ex vivo (Fig. 5a,b) . Instead, Ly6C hi monocytes and neutrophils did not depend on Candidalysin for IL-1β and CXCL1 production, suggesting that other, as-yet unidentified, fungal factors activate this pathway in these phagocytes. Together, our data shows that Candidalysin acts on microglia to stimulate IL-1β release, which then drives the CXCL1 production that is required for protective neutrophil CNS recruitment.
Candidalysin drives differing glial IL-1β-CXCL1 ex vivo. To gain mechanistic insights into how microglia respond to Candidalysin, we cultured the microglia cell line BV-2 (ref. 25 ) in the presence of synthetic Candidalysin, and measured IL-1β and CXCL1 in the supernatants. In line with our in vivo work, we found time-and dose-dependent IL-1β production by BV-2 cells in response to Candidalysin (Fig. 6a) . However, we did not detect CXCL1 from BV-2 cells stimulated under these conditions. We first considered that this could be due to Candidalysin-induced damage which may ∆184-279 , n = 11 (b); CAI4 + CIp10, n = 6 and sap4/5/6∆/∆ + CIp10, n = 6 (e)) and neutrophil recruitment (a,c,e: hgc1∆/∆, n = 10 and hgc1∆/∆ + HGC1, n = 10 (a); BWP17, n = 7, ece1∆/∆, n = 7, ece1∆/∆ + ECE1, n = 7 and ece1∆/∆ + ECE1 ∆184-279 , n = 11 (c); CAI4 + CIp10, n = 6 and sap4/5/6∆/∆ + CIp10 n = 7 (e)) and as described below (c,d). The histology in c (right) is from 24 h post-infection, stained with periodic acid-Schiff (PAS). Scale bar, 50 µm. In d, whole-brain homogenates from animals infected with the indicated strains were isolated at 24 h post-infection and analyzed for IL-1β and CXCL1 using ELISA (BWP17, n = 8-10, ece1∆/∆, n = 8-10, ece1∆/∆ + ECE1, n = 6-11 and ece1∆/∆ + ECE1 ∆184-279 , n = 7-11). Each symbol represents an individual mouse. Data are pooled from two to four independent experiments and are shown as mean ± s.e.m., analyzed using the unpaired, two-tailed, Student's t-test, or the two-tailed, Mann-Whitney U-test (a, left). *P < 0.05, **P < 0.01, ***P < 0.005; NS, not significant.
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NATuRe IMMuNoLogy prevent BV-2 cells from producing CXCL1 after IL-1β secretion. Indeed, as shown for epithelial cells 19 , Candidalysin mediated dosedependent cell damage to BV-2 microglia (Fig. 6b) . Alternatively, additional signals beyond IL-1β, derived from non-microglial CNS cells, might be required for microglial CXCL1 induction, acting in trans. To test this hypothesis, we co-cultured BV-2 cells with immortalized C8-D1A astrocytes in the presence of Candidalysin and measured IL-1β and CXCL1 in the supernatants. We chose astrocytes because they are known to respond to IL-1β to produce inflammatory mediators, including CXCL1, in other models of CNS inflammation [26] [27] [28] . We found that astrocytes responded to Candidalysin to produce CXCL1 (Fig. 6c) , but not IL-1β (data not shown), and that CXCL1 production greatly increased when astrocytes and microglia were co-cultured (Fig. 6c) . To confirm that microglia are a relevant cellular source of CXCL1 detected during microglia-astrocyte co-culture, we performed intracellular staining for CXCL1 and found BV-2 microglia to be significant producers of CXCL1 in response to Candidalysin, but only when astrocytes were present (Fig. 6d) . Therefore, astrocytes provide additional signals to microglia that are needed for CXCL1 production in response to Candidalysin.
Next we investigated the pathway activated by Candidalysin in BV-2 microglia to produce IL-1β. Candidalysin was previously shown, in epithelial cells, to activate c-Fos in a p38-dependent Fig. 3 and intracellular staining for IL-1β (unstimulated, n = 8 animals; zymosan, n = 4; LPS n = 6) (a), and CXCL1 (unstimulated, n = 12; zymosan, n = 6; LPS n = 9) (b), were analyzed by flow cytometry. Box-and-whisker plots show the minimum/maximum values (whiskers), the 25th/75th percentiles and the median. Data are pooled from two to four independent experiments and were analyzed using the unpaired, two-tailed, Student's t-test. *P < 0.05, **P < 0.01. Representative staining is shown for LPS-stimulated microglia (gated as in Fig. 3 ) from WT mice infected with indicated strains, or BWP17-infected, cytokine-deficient mutants as the control.
NATuRe IMMuNoLogy manner and the phosphatase MKP1 (ref. 20 ). We thus asked whether the same pathways are activated by Candidalysin in BV-2 microglia. We found that Candidalysin sequentially and dose dependently activated MKP1 and c-Fos (Fig. 6e) , and chemical inhibition of p38 or c-Fos greatly reduced IL-1β release from Candidalysin-stimulated BV-2 cells (Fig. 6f) . Therefore, microglia produce IL-1β in response to Candidalysin via activation of p38 and c-Fos.
The microglial IL-1β-CXCL1 response requires CARD9. CARD9 deficiency is the only known risk factor that uniquely predisposes to CNS candidiasis in the absence of iatrogenic intervention 2, 5 . We first examined whether CARD9 deficiency causes developmental defects in resident microglia, but found no defects in abundance or activation markers at a steady state in Card9 -/-microglia, which accumulated in similar numbers to WT microglia after fungal infection (see Supplementary Fig. 5 ). As C. albicans activates the microglial IL-1β-CXCL1 axis to regulate protective neutrophil CNS recruitment, we next analyzed the dependence on CARD9 for induction of this pathway in microglia post-infection in vivo. We hypothesized that CARD9 is required for these functions, because microglia highly express CARD9 and we previously found reduced transcription of CXC chemokines by Card9 -/-microglia harvested from the C. albicans-infected brain 5 . We infected Card9 +/+ and Card9
-/-animals with WT Candidalysin-expressing C. albicans, isolated phagocytes from the brain, and measured pro-IL-1β and CXCL1 production after ex vivo restimulation. We found greatly decreased frequencies of CXCL1 + and pro-IL-1β + cells in the fungus-infected Card9 -/-brain, and these decreases mapped to microglia (Fig. 7a,b) . As production and secretion of mature IL-1β depend on pro-IL-1β expression and consecutive inflammasome-dependent processing, we asked whether microglia depend on CARD9 for pro-IL-1β transcription and/or inflammasome activation. We sorted 5 C8-D1A astrocytes, and CXCL1 in the supernatant was analyzed using ELISA (n = 10 individual culture wells) or by intracellular flow cytometry (n = 3-5 individual culture wells; data shown with the mean) (c). Microglia and astrocytes were distinguished by CD45 staining, and CXCL1 production was assessed within CD45 + (microglia) and CD45 -(astrocyte) gates (d). The histogram is gated on CD45 + microglia. e, To measure c-Fos and pMKP1/2 activation, BV-2 cells were stimulated with the indicated Candidalysin concentrations for 30 or 120 min, and BV-2 cells were then lysed and analyzed for c-Fos and pMKP1/2 by immunoblot, normalizing to β-actin. Immunoblots shown are representative of two independent experiments. f, BV-2 cells were cultured in the presence of the indicated c-Fos and p38 inhibitors for 2 h before being stimulated with 20 µmol l -1 Candidalysin, and IL-1β was measured in the supernatant using ELISA after 24 h (data shown as mean ± s.e.m.; n = 6 individual culture wells). All data are pooled from two independent experiments and were analyzed using the one-way analysis of variance (ANOVA). *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.0001.
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-/--infected brains using FACS, and examined Il1b transcription using qRT-PCR, and levels of pro-IL-1β and cleaved and pro-caspase-1 using immunoblotting. We found greatly decreased Il1b transcription in Card9 -/-microglia, which we confirmed at the protein level (Fig. 7c,d ). These data are in line with the reported CARD9-dependent pro-IL-1β transcription in bone marrow-derived dendritic cells after a viral infection 29 . We also found greatly reduced cleaved caspase-1 in Card9 (Fig. 7d) , indicating that Card9 also operates at the level of inflammasome activation for IL-1β production. Given that c-Fos mediated Candidalysin-induced IL-1β production by BV-2 cells, we measured c-Fos expression in WT and Card9 -/-microglia using immunoblotting and found greatly decreased c-Fos expression in Card9 -/-microglia (Fig. 7d) . Next we examined the NLRP3 inflammasome in WT and Card9 -/-microglia sorted using FACS. We focused on NLRP3 because CARD9 was reported to negatively regulate NLRP3 activation during macrophage salmonella infection 30 , and we had recently shown that Candidalysin activates NLRP3 in bone marrow-derived macrophages 31 . We found greatly decreased NLRP3 protein expression in Card9 -/-microglia (Fig. 7e) . Of interest, Nlrp3 -/-animals had greatly decreased neutrophil accumulation into the C. albicans-infected brain and increased fungal load post-infection, consistent with a potential role of Card9-dependent NLRP3-inflammasome activation for protective neutrophil influx in the fungus-infected CNS (Fig. 7f) . Together, microglia require CARD9 for c-Fos activation and production of mature IL-1β via Il1b transcriptional regulation and inflammasome activation, to activate the IL-1β-CXCL1 axis in response to fungal invasion.
Microglial CARD9 deletion causes CNS fungal invasion. Next we directly examined the impact of genetic Card9 deletion, specifically within microglia, by utilizing mice that expressed tamoxifen-inducible Cre recombinase under the Cx3cr1 promoter (Cx3cr1 CreER ) 32 . These mice have been used to genetically manipulate long-lived CX3CR1 + microglia, while leaving short-lived CX3CR1 + monocytes and monocyte-derived macrophages unaffected. We bred Cx3cr1
CreER animals to Card9-floxed mice 11 , tamoxifen pulsed the progeny to activate Cre expression, and waited 4-6 weeks to allow replenishment of short-lived, non-microglial CX3CR1 + cells from the bone marrow, whereas long-lived microglia remained Card9 deficient (see Supplementary Fig. 6 ). C. albicans infection of Card9
CreER+/-animals revealed an important dependence on Card9 expression by the long-lived CX3CR1
+ cellular compartment for control of fungal growth in the brain (Fig. 8a) , although renal fungal control was unaffected in microglia-specific, conditional Card9 -/-mice (Fig. 8a) .
To analyze whether the susceptibility to brain infection in Card9 fl/fl Cx3cr1 CreER+/-mice was related to a neutrophil recruitment defect, we quantified neutrophils within the infected brains of Card9 fl/fl Cx3cr1 CreER+/-mice and their Cre-negative littermates. We found that microglial deletion of Card9 greatly reduced the protective early influx of neutrophils into the fungus-infected brain (Fig. 8b) , which correlated with greatly decreased expression of microglial pro-IL-1β and CXCL1 in the conditional Card9 -/-mice (Fig. 8c) . Together, our data shows that CARD9-expressing microglia orchestrate control of fungal invasion of the brain by responding to fungus-secreted Candidalysin to produce IL-1β-induced CXCL1, which recruits CXCR2-expressing neutrophils that mediate CNS fungal clearance (see Supplementary Fig. 7) .
Discussion
In the present study, we demonstrated the critical contribution of CARD9-mediated IL-1β and CXCL1 in recruiting protective neutrophils to the fungus-infected CNS. We identified microglia as major producers of CARD9-dependent IL-1β and CXCL1 during C. albicans CNS invasion, and the fungus-secreted toxin Candidalysin as a critical pathogen-derived factor activating this pathway. Our study offers insights into the network of host and fungal factors that protect against CNS fungal invasion, and unveil the mechanism of CNS fungal susceptibility in inherited CARD9 deficiency.
Systemic candidiasis is a leading cause of nosocomial bloodstream infection with a mortality rate greater than 50% despite therapy 33 . Neutropenia is the major predisposing factor for systemic candidiasis and Candida CNS invasion in particular 1, 34 . Moreover, CNS invasion is prevalent during systemic candidiasis in low-birthweight neonates and also occurs as an iatrogenic complication after neurosurgical procedures 35, 36 . Strikingly, CARD9 deficiency is a primary immunodeficiency disorder characterized by heightened susceptibility to fungal infections, of which CNS candidiasis is a hallmark 2, 34 . CARD9 deficiency is the only known primary immunodeficiency disorder that causes fungus-specific infection susceptibility without other infectious or non-infectious manifestations, and the only one that causes fungal disease in which CNS is a primary target tissue 17 . We have previously demonstrated that Candida CNS disease in CARD9 deficiency is caused by a fungus-and brainspecific defect in neutrophil recruitment 5 . CNS neutropenia is now confirmed in several CARD9-deficient patients with CNS candidiasis 7, 37, 38 . None the less, how CARD9 mediates protective neutrophil trafficking into the fungus-infected CNS remained unclear.
Our analysis of mice deficient in several CLRs, cytokine and chemokine circuits uncovered: (1) the functional redundancy 
Cx3cr1
CreER+/-, n = 8). Data are pooled from two to four independent experiments and are shown as mean ±s.e.m., analyzed using the two-tailed, Mann-Whitney U-test (a) or the two-tailed, unpaired, Student's t-test (b,c). *P < 0.05, **P < 0.01.
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among CLRs, which may suggest the presence of yet-undiscovered CARD9-coupled receptors for driving tissue-specific antifungal defense; (2) the indispensable role of the CARD9 partner MALT1 in controlling CNS fungal invasion independent of neutrophil recruitment, which implies that MALT1 -/-patients may be at risk for CNS fungal disease; and (3) the critical contribution of IL-1β-CXCL1-mediated neutrophil recruitment for control of CNS fungal invasion. CXCR2 was known to mediate neutrophil trafficking during viral infection, parasitic meningitis 39 and fungal pneumonia 40 , and in the present study we reveal its importance for recruiting neutrophils during fungal CNS infection, principally through binding CXCL1. In contrast, CCR1, CXCR1 and LTB4R1 are dispensable despite their regulation of neutrophil recruitment and function in other C. albicans-infected tissues [13] [14] [15] . These studies further underscore the organ-and context-specific dependence on chemotactic molecules for protective host immunity.
We have shown that IL-1β is required for CXCL1 induction, in line with earlier work showing IL-1β-induced CXCL1 production controlling neutrophil accumulation during bacterial peritonitis and autoimmune, traumatic or bacterial neuroinflammation 10, 41, 42 . Importantly, microglia are the primary myeloid cellular source of IL-1β-dependent CXCL1 production in vivo. During oral candidiasis, IL-1R is also required for neutrophil accumulation to the oral mucosa 8 , as we have shown for systemic infection in the brain. However, further attesting to the presence of tissue-specific, antiCandida immune response cues, the IL-1R-dependent response in the oral epithelium is largely controlled by IL-1α released by damaged keratinocytes 8 , whereas we found that IL-1α plays a modest role in controlling fungal invasion of the brain. In fact, IL-1α release by both oral and vaginal epithelial cells is driven by exposure to the fungus-secreted toxin Candidalysin [19] [20] [21] . Candidalysin enables the establishment of C. albicans mucosal infections, because Candidalysin-deficient strains are avirulent in these models 19, 21 . In contrast, we found that Candidalysin-deficient strains are hypervirulent for the brain, associated with decreased IL-1β and CXCL1 production and impaired neutrophil recruitment. These results indicate that Candidalysin is not only a classic virulence factor, but also an immune modulator, which exerts contextspecific effects on the immune system. We propose that this dual function of Candidalysin is the result of a co-evolutionary event: the fungus developed an efficient toxin to damage host membranes and, in response, the host evolved a sensitive Candidalysin detection system to defend against this common mucosal pathogen. Whether Candidalysin is recognized by a specific microglial innate receptor to mediate the protective IL-1β-CXCL1 axis is unclear, because the toxin mediates cellular damage that could also activate glial cells. Therefore, identification of how host epithelial and immune cells recognize Candidalysin merits investigation.
We found that Candidalysin selectively activates microglia for IL-1β and CXCL1 production, a self-renewing macrophage population that contributes toward neuroinflammation in neurodegenerative disorders, and promotes pathogen and dead cell clearance within the CNS 43 . It is interesting that, downstream of Candidalysininduced microglial IL-1β secretion, which occurs via c-Fos activation, we show that additional signals derived from astrocytes acting in trans are required for microglia to secrete CXCL1. Whether direct microglia-astrocyte contact is required or astrocyte-derived soluble factors acting on microglia are needed remains unknown. Indeed, microglia are known to interact with astrocytes to drive or suppress inflammation 44, 45 . Therefore, the molecular factors that drive microglia-astrocyte cross-talk within the fungus-infected brain warrant further investigation.
Last, we examined the dependence on CARD9 for the microglia-mediated, IL-1β−CXCL1-dependent pathway that recruits protective neutrophils, using fully Card9-deficient and conditional microglia-specific Card9 -/-mice. We showed that CARD9 is critical for both c-Fos activation and the production of both IL-1β and CXCL1 by microglia in the infected CNS, operating at the levels of both transcriptional pro-IL-1β regulation and inflammasome activation for IL-1β generation, with NLRP3 being at least partly involved, as shown with microsporum infection 46 . Together, this data sheds light on the pathogenesis of inherited CARD9 deficiency by outlining a pathway of CARD9-dependent microglial production of sequential IL-1β and CXCL1, which recruits protective neutrophils into the fungus-infected CNS.
Future studies should examine whether Card9 promotes microglial innate functions beyond orchestrating neutrophil recruitment such as fungus uptake and killing. Of note, the phenotype of microglia-specific, conditional, knockout mice is less severe than that of Card9 -/-mice, which may reflect the important role of astrocytes expressing Card9 post-infection 5 , in priming microglial CXCL1 production. Future work should examine whether non-CNS, tissue-resident macrophages, such as Kupffer cells, differentially depend on Card9 for IL-1β−CXCL1-mediated neutrophil recruitment, as previously shown for differential macrophage and dendritic cell-induced, Card9-dependent, tumor necrosis factor-α 47 ; this will help further understanding of the CNS specificity of fungal infections in CARD9 deficiency. Beyond understanding the pathogenesis of inherited CARD9 deficiency, our findings have important implications for recognizing the potential fungal infection risk in patients who are increasingly receiving Syk inhibitors for autoimmune and malignant diseases 48, 49 . Surveillance of Syk inhibitor-treated patients and research into conditional Syk-deficient mice will help determine their CNS fungal disease risk.
In summary, we present evidence of an intricate host immune pathway that protects the CNS from invading fungi. This work uncovers the complex interactions occurring between the host and the most common human fungal pathogen within the CNS, and sheds mechanistic light on the pathogenesis of inherited CARD9 deficiency.
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CreER+/-mice and littermate controls. Soon after weaning (~5-6 weeks old), Card9
CreER+/-mice and their controls were treated with two 10 mg doses of tamoxifen (Sigma) administered in corn oil by oral gavage, given 48 h apart. After 4-6 weeks, these animals were infected and analyzed as outlined in the figure legends. All experimentation conformed to conditions approved by the Animal Care and Use Committee of the National Institute of Allergy and Infectious Diseases (NIAID).
Candidiasis model and fungal burden determination. Candida albicans strains used in this study were SC5314, BWP17, ece1∆/∆, ece1∆/∆ + ECE1, ece1∆/∆ + ECE1 ∆184-279 (ref. 19 ), CAI4 + CIp10 and sap4/5/6∆/∆, and hgc1∆/∆ and hgc1∆/∆ + HGC1 (ref. Analysis of brain neutrophil recruitment by FACS. Leukocytes were isolated from brains using previously described methods 53 , resuspended in PBS and stained with live/dead fluorescent dye (Invitrogen) for 10 min on ice. Cells were then stained with fluorophore-conjugated antibodies in the presence of anti-CD16/32 and 0.5% bovine serum albumin (BSA) for 30 min on ice. Samples were washed in PBS/0.5% BSA/0.01% sodium azide and acquired using the BD Fortessa instrument equipped with BD FACS Diva software (BD Biosciences). FlowJo (TreeStar) was used for the final analysis. Anti-mouse antibodies used in this study were: CD45 (30-F11), CD11b (M1/70), both from eBiosciences, and Ly6G (1A8), Ly6C (AL-21), both from BD Biosciences.
Histology. Brains were removed from infected mice at the indicated time points and fixed in 10% formalin for 24 h before embedding in paraffin wax. Tissue sections were stained with PAS.
Measurement of cytokines and chemokines in brain homogenates. Infected brains were isolated at 24 h post-infection and homogenized in 1 ml PBS supplemented with 0.05% Tween20 and a protease inhibitor cocktail (Roche). Homogenized brains were centrifuged twice to remove debris and the resulting supernatants snap-frozen on dry ice and stored at -80 °C before analysis. IL-1β and CXCL1 concentrations in the homogenates was determined by ELISA (R&D Systems), following the manufacturers' instructions.
Ex vivo restimulations and intracellular FACS analysis. Animals were infected with 2 × 10 5 c.f.u. of the indicated C. albicans strains intravenously, and brain leukocytes isolated 24 h later. For these experiments, brains were first digested in RPMI medium supplemented with 0.8 mg ml −1 Dispase (Gibco), 0.2 mg ml
Collagenase Type 4 (Worthington) and 0.1 mg ml −1 DNAse (Roche) at 37 °C for 30 min, then pipetted vigorously to create a homogeneous suspension. These suspensions were centrifuged (1,500 r.p.m., 5 min, 4 °C), the pellets resuspended in 5 ml 40% Percoll (GE Healthcare) and centrifuged again at 1,700 r.p.m. for 20 min at 4 °C to remove myelin. Cell pellets were washed in RPMI medium supplemented with 10% heat-inactivated fetal bovine serum and penicillin/streptomycin (Invitrogen), and added to FACS tubes for stimulations. Cells were incubated for 4 h at 37 °C in the presence of 5 μg ml -1 brefeldin A (Sigma) and, where indicated, 1 μg ml -1 LPS (Sigma) or 62.5 μg ml −1 depleted zymosan (Sigma). After stimulation, cells were washed in PBS and stained for surface markers as above. Fixation/permeabilization was performed using the eBioscience Foxp3 staining kit, and staining for CXCL1 (IC4532R, from R&D Systems) or pro-IL-1β (NJTEN3, from eBioscience) performed overnight at 4 °C.
Samples were washed once in PBS/0.5% BSA/0.01% sodium azide before acquisition using the BD Fortessa instrument equipped with BD FACS Diva software (BD Biosciences). FlowJo (TreeStar) was used for the final analysis. CXCL1
+ and pro-IL-1β + cells were determined by employing similar staining and gating in animals deficient in these mediators (Cxcl1 -/-, Il1b -/-) as negative controls.
Cell culture and Candidalysin stimulations. BV-2 cells were kindly provided by F. Crews (University of North Carolina School of Medicine). C8-D1A astrocytes were kindly provided by D. McGavern (NINDS, NIH). Details about the validation and use of these cell lines are provided in the Life Sciences Reporting Summary. BV-2 cells were maintained at 37 °C, 5% CO 2 in RPMI medium supplemented with l-glutamine and HEPES (pH 7.0-7.4; Corning), 10% heat-inactivated fetal bovine serum and penicillin/streptomycin (Invitrogen). DMEM medium was used as the base medium for C8-D1A culture, with the same supplements as listed above and cultured as for BV-2. For BV-2 single culture experiments, cells were lifted using cell scrapers and seeded into 24-well plates at 5 × 10 5 cells per well (BV-2) and left to adhere for 2 h at 37 °C with 50 ng ml -1 LPS (Sigma), T-5224 (APExBIO) and/or SB203580 (Adipogen) (see figure legends for details of each experiment). After 2 h, recombinant Candidalysin peptide (Peptide Protein Research) was added to the cells at the indicated concentrations and incubation at 37 °C continued. For co-culture experiments, 3 × 10 5 C8-D1A astrocytes were added to each well of a 24-well plate and incubated overnight at 37 °C. BV-2 cells and Candidalysin were added as described above. In both types of experiments, supernatants or cells were collected at the indicated time points after Candidalysin addition and analyzed for IL-1β and CXCL1 by ELISA (R&D Systems), and CXCL1 staining by intracellular flow cytometry or immunoblot.
Immunoblot analysis. Whole-cell lysates were suspended in RIPA buffer containing protease and phosphatase inhibitors (Thermo Scientific). Lysates were separated in SDS-PAGE and transferred to a 0.2-μm nitrocellulose membrane (Bio-Rad Laboratories). The membrane was incubated with the following primary antibodies: phospho-MPK1/MPK2 polyclonal (Ser were FACS sorted into sterile sorting buffer (Hanks' balanced salt solution supplemented with 2 mM EDTA, 10% FCS, 100 U ml -1 penicillin, 100 μg ml -1 streptomycin) using an FACS Aria instrument for downstream qRT-PCR and immunoblot analyses. Purity of cells was greater than 95%, on average. In some experiments (qRT-PCR of CLRs in brain-resident microglia; see Supplementary Fig. 1 ), microglia were instead sorted by magnetic separation using anti-CD11b microbeads (Miltenyi). Cells were then centrifuged (1,500 r.p.m., 5 min, 4 °C) and resuspended in TRIzol for RNA purification or radioimmunoprecipitation assay buffer for downstream immunoblot analysis. Depending on the experiment, up to five animals were pooled for individual sorts, or individual mice were analyzed separately (see figure legends for details).
Generation of cDNA and qRT-PCR. RNA was extracted from sorted brain myeloid cells (defined using the gating strategy shown in Supplementary  Fig. 2 ) using TRIzol (Invitrogen) and the RNeasy kit (Qiagen) following the manufacturer's protocol. Purified RNA was used as a template for cDNA generation using the qScript cDNA SuperMix kit (Quanta Biosciences) with oligo(dT) and random primers. Quantitative PCR was performed using TaqMan detection (PerfeCTa qPCR FastMix ROX; Quanta BioSciences) with the 7900HT Fast Real-Time PCR System (Applied Biosystems). All qPCR assays were performed in duplicate and the relative gene expression of each gene was determined after normalization with glyceraldehyde 3-phosphate dehydrogenase transcript levels using the ΔΔCT method. TaqMan primers/ probes (Clec7a, Clec4n, Clec4d, Clec4e, Il1b, Card9, Gapdh) were predesigned by Applied Biosystems.
Statistics. Statistical analyses were performed using GraphPad Prism 7.0 software. Details of individual tests are included in the figure legends. In general, data was tested for normal distribution using the Kolmogorov-Smirnov normality test and analyzed accordingly using the two-tailed, unpaired, Student's t-test or the two-tailed, Mann-Whitney U-test. In cases where multiple data-sets were analyzed, two-way ANOVA was used with Bonferroni's correction. In all cases, P < 0.05 was considered significant. Further details relating to power calculations, randomization and blinding are described in the Life Sciences Reporting Summary. Last updated by author(s): Mar 12, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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